Synthesis and investigation of novel spiro-isoxazolines as anti-cancer agents

  • Prasanta Das
  • , Ann O. Omollo
  • , Lungile J. Sitole
  • , Eric McClendon
  • , Edward J. Valente
  • , Drazen Raucher
  • , Leslie R. Walker
  • , Ashton T. Hamme

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Abstract

A series of structurally diverse 4-bromo spiro-isoxazolines possessing a variety of aromatic and aliphatic substituents at the 3 position, were synthesized through a 1,3-dipolar cycloaddition followed by intramolecular cyclization of a pendant hydroxyl or carboxylic acid group. The biochemical antiproliferative activity was evaluated in vitro by using two breast cancer cell lines (MCF-7 and MDA-MB-231) and two prostate cancer cell lines (PC-3 and DU-145) using the MTT viability assay, and the IC50 values were obtained. Spiro-isoxazoline derivatives bearing a p-chloro or an o-dichloro aromatic substituent at the 3-position of the isoxazoline showed considerable antitumor activities in all four cell lines with IC50 values ranging from 43 μM to 56 μM.

Original languageEnglish
Pages (from-to)1794-1797
Number of pages4
JournalTetrahedron Letters
Volume56
Issue number14
DOIs
Publication statusPublished - 1 Apr 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 1,3-Dipolar cycloaddition
  • Bioevaluation
  • Regioselectivity
  • Spiro-isoxazolines
  • Stereoselective intramolecular cyclization

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis and investigation of novel spiro-isoxazolines as anti-cancer agents'. Together they form a unique fingerprint.

Cite this